Form 4 for TXG 10x Genomics, Inc.

Accepted 2021-09-24 00:00:00 ET · period of report 2021-09-23 · accession 0001209191-21-057709 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-09-24	2021-09-23	TXG	Kosaraju Sridhar	Dir	S - Sale	$159.04	-1,500	8,600	-15%	-$238.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-09-23	S	D	1,100	$159.52	7,500	I See Footnote	—	—	(F4) This transaction was executed in multiple trades at prices ranging from $158.94 to $159.81. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F3) These shares are held by the Kosaraju Family Trust.
2	Common	Class A Common Stock	2021-09-23	S	D	400	$157.71	8,600	I See Footnote	—	—	(F2) This transaction was executed in multiple trades at prices ranging from $157.20 to $157.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F3) These shares are held by the Kosaraju Family Trust.